Thomas McFall

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Top Venues

Science signaling

Scientific reports

Molecular & cellular oncology

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas McFall, Michael Trogdon, Anita C Guizar, John F Langenheim, Laura Sisk-Hackworth, Edward Cooper Stites
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP. NPJ precision oncology 6 (1) (2022)
Thomas McFall, Edward Cooper Stites
A mechanism for the response of KRASG13D expressing colorectal cancers to EGFR inhibitors. Molecular & cellular oncology 7 (2) (2020)
Thomas McFall, Jolene K Diedrich, Meron Mengistu, Stacy L Littlechild, Kendra V Paskvan, Laura Sisk-Hackworth, James J Moresco, Andrey S Shaw, Edward Cooper Stites
A systems mechanism for KRAS mutant allele-specific responses to targeted therapy. Science signaling 12 (600) (2019)
Mugdha Patki, Thomas McFall, Rayna Rosati, Yanfang Huang, Agnes Malysa, Lisa Polin, Abigail Fielder, Mike R Wilson, Fulvio Lonardo, Jessica Back, Jing Li, Larry H Matherly, Gerold Bepler, Manohar Ratnam
Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Scientific reports 8 (1) (2018)